Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hearing Loss × Atorvastatin × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ototoxicity 1 Hearing Loss 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Colitis, Ulcerative 1 Carcinoma, Squamous Cell 1

Interventions

sodium thiosulfate 1 Platinum 1 Magnetic Resonance Spectroscopy 1 Hearing 1 Cisplatin 1 Atorvastatin 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04915183 2026-03-09

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡